These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3878079)

  • 1. Beta-lactamase inhibition: therapeutic advances. Proceedings of a symposium. Fort Lauderdale, Florida, March 22-23, 1985.
    Am J Med; 1985 Nov; 79(5B):1-196. PubMed ID: 3878079
    [No Abstract]   [Full Text] [Related]  

  • 2. Infection in women. Clinical experience with beta-lactamase inhibitors.
    Holloway WJ
    J Reprod Med; 1988 Jun; 33(6 Suppl):595-7. PubMed ID: 3294405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of obstetric and gynecologic infections, with an emphasis on beta-lactamase-producing organisms.
    McGregor JA; Christiansen FB
    J Reprod Med; 1988 Jun; 33(6 Suppl):591-4. PubMed ID: 3294404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ticarcillin disodium and clavulanate potassium in the treatment of post-cesarean-section endomyometritis.
    Sanders CV; Pastorek JG; Miller JM; Aldridge KE
    J Reprod Med; 1988 Jun; 33(6 Suppl):584-7. PubMed ID: 3260949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ticarcillin-clavulanic acid therapy in severe infections.
    Van der Auwera P; Legrand JC
    Drugs Exp Clin Res; 1985; 11(11):805-13. PubMed ID: 3836862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of endomyometritis.
    Yonekura ML
    J Reprod Med; 1988 Jun; 33(6 Suppl):579-83. PubMed ID: 3260948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ticarcillin and ticarcillin/clavulanic acid on the in-vitro activity of human granulocytes against beta-lactamase-producing Klebsiella pneumoniae.
    Cuffini AM; de Renzi G; Tullio V; Paizis G; Carlone NA
    Int J Tissue React; 1995; 17(5-6):199-203. PubMed ID: 8835630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Refractory respiratory tract infections. 7. Trends in the development of new chemotherapeutic agents for respiratory tract infections. c. Combinations of beta-lactam antibiotics and beta-lactamases inhibitors].
    Tamura M; Ito T
    Nihon Rinsho; 1987 Mar; 45(3):583-7. PubMed ID: 3037135
    [No Abstract]   [Full Text] [Related]  

  • 9. [New antimicrobial agent series XXXVII: potassium clavulanate/Ticarcillin sodium].
    Fujimori I
    Jpn J Antibiot; 1991 Apr; 44(4):365-87. PubMed ID: 1880918
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of in vitro kinetic models in the evaluation of beta-lactamase inhibitors.
    White A; Cooper C; Stokes D
    Chemioterapia; 1987 Jun; 6(2 Suppl):202-4. PubMed ID: 3509934
    [No Abstract]   [Full Text] [Related]  

  • 11. Parenteral beta-lactamase inhibitor combinations for clinical use.
    Manzella JP
    Am Fam Physician; 1995 May; 51(7):1695-8. PubMed ID: 7754928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bactericidal effects of ticarcillin-clavulanic acid against beta-lactamase-producing bacteria in vivo.
    Boon RJ; Beale AS; Sutherland R
    Antimicrob Agents Chemother; 1986 May; 29(5):838-44. PubMed ID: 3524431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European experience of timentin in combination with aminoglycosides as empirical treatment in febrile neutropenic patients.
    Croydon E; Weerts D
    Chemioterapia; 1987 Jun; 6(2 Suppl):405-7. PubMed ID: 3334585
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of ticarcillin plus clavulanic acid with clindamycin and gentamicin in the treatment of postcesarean endomyometritis.
    Apuzzio JJ; Ganesh V; Kaminski Z; Bergen B; Holland B; Louria DB
    Surg Gynecol Obstet; 1988 May; 166(5):413-7. PubMed ID: 3259017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of penetrating abdominal trauma and gynecologic infections.
    Levine DP; Wilson RF
    J Reprod Med; 1988 Jun; 33(6 Suppl):598-602. PubMed ID: 3294406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ticarcillin--clavulanic acid (Timentin).
    Med Lett Drugs Ther; 1985 Aug; 27(694):69-70. PubMed ID: 3894901
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical trial of the efficacy and safety of ticarcillin and clavulanic acid.
    Roselle GA; Bode R; Hamilton B; Bibler M; Sullivan R; Douce R; Staneck JL; Bullock WE
    Antimicrob Agents Chemother; 1985 Mar; 27(3):291-6. PubMed ID: 3888101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of Augpenin (clavulanic acid-ticarcillin) in urinary tract infections: especially against beta-lactamase producing strains].
    Shiono A; Kurihara J; Hayashi M; Suzuki T; Imai K; Yamanaka H; Takezawa Y; Kiren H; Okabe K; Tomaru Y
    Hinyokika Kiyo; 1993 Aug; 39(8):777-82. PubMed ID: 8379483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ticarcillin/clavulanate in the treatment of pelvic infections.
    Lucas MJ; Cox SM; Roark ML; Cunningham FG
    J Reprod Med; 1990 Mar; 35(3 Suppl):343-7. PubMed ID: 2181121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of a ticarcillin-clavulanic acid combination in severe infections in adults].
    Lacut JY; Quentin C; Cardoso-Mendes I; Dupon M
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):591-5. PubMed ID: 3937132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.